Abstract
Background
The diagnosis of malignant glioma confers a poor prognosis in the pediatric population. In the adult demographic, racial disparities exist with respect to access to care and survival. Yet to date no efforts have been made to characterize racial disparities in the care of malignant pediatric gliomas. Correspondingly, the aim of this study was to understand if racial disparities exist in the setting of malignant pediatric gliomas.
Methods
All pediatric malignant gliomas patients with known race status (White, Black, Other) in the US National Cancer Database (NCDB) between the years 2005–2016 were retrospectively reviewed. Demographic, socioeconomic and clinical data were then abstracted and analyzed by comparison and regression techniques.
Results
A total of 1803 pediatric malignant glioma cases were identified, with 48% female and a median age of 8 years old. Brainstem locations were reported in 48% of cases. Socioeconomically, there were statistically significant differences with respect to insurance status, yearly income, household education level and metropolitan residences between the racial groups (all P < 0.01). With respect to treatment, there was statistical difference in the proportion of patients treated with surgical resection (White 43% vs Black 34% vs Other 37%, P = 0.02). There were no differences between race groups for radiation therapy (P = 0.73) or chemotherapy (P = 0.12). The odds of surgical resection were significantly less in the Black group compared to the White group (OR 0.69, P < 0.01), although there was no difference in overall survival between the two groups in those treated with (P = 0.44) or without (P = 0.27) surgical resection. Primary associations of surgical resection in the Black group were brainstem location (P < 0.05) and lower yearly household income quartiles (P < 0.05).
Conclusions
Racial disparities exist amongst the management of pediatric malignant gliomas, with undefined impact on survival and quality of life. In this perspective, we identified associations between Black patients and access to surgical treatment. Understanding that there are many elements to patient care, including quality of life, should encourage all clinicians and carers to consider racial disparities appropriately when managing malignant pediatric glioma patients.
Similar content being viewed by others
References
Tamber MS, Rutka JT (2003) Pediatric supratentorial high-grade gliomas. Neurosurg Focus 14(2):e1. https://doi.org/10.3171/foc.2003.14.2.2
Ostrom QT, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS (2021) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014–2018. Neuro-Oncology 23(12 Suppl 2):iii1–iii105. https://doi.org/10.1093/neuonc/noab200
Broniscer A, Gajjar A (2004) Supratentorial high-grade astrocytoma and diffuse brainstem glioma: two challenges for the pediatric oncologist. Oncologist 9(2):197–206. https://doi.org/10.1634/theoncologist.9-2-197
Pollack IF (1994) Brain tumors in children. N Engl J Med 331(22):1500–1507. https://doi.org/10.1056/nejm199412013312207
Braunstein S, Raleigh D, Bindra R, Mueller S, Haas-Kogan D (2017) Pediatric high-grade glioma: current molecular landscape and therapeutic approaches. J Neurooncol 134(3):541–549. https://doi.org/10.1007/s11060-017-2393-0
Parsons SK, Kumar AJ (2019) Adolescent and young adult cancer care: financial hardship and continued uncertainty. Pediatr Blood Cancer 66(4):e27587. https://doi.org/10.1002/pbc.27587
Ostrom QT, Cote DJ, Ascha M, Kruchko C, Barnholtz-Sloan JS (2018) Adult glioma incidence and survival by race or ethnicity in the United States from 2000 to 2014. JAMA Oncol 4(9):1254–1262. https://doi.org/10.1001/jamaoncol.2018.1789
Lerro CC, Robbins AS, Phillips JL, Stewart AK (2013) Comparison of cases captured in the National Cancer Data Base with those in population-based central cancer registries. Ann Surg Oncol 20(6):1759–1765. https://doi.org/10.1245/s10434-013-2901-1
Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45(6):613–619. https://doi.org/10.1016/0895-4356(92)90133-8
Boffa DJ, Rosen JE, Mallin K, Loomis A, Gay G, Palis B, Thoburn K, Gress D, McKellar DP, Shulman LN, Facktor MA, Winchester DP (2017) Using the National Cancer Database for outcomes research: a review. JAMA Oncol 3(12):1722–1728. https://doi.org/10.1001/jamaoncol.2016.6905
Goyal A, Zreik J, Brown DA, Kerezoudis P, Habermann EB, Chaichana KL, Chen CC, Bydon M, Parney IF (2021) Disparities in access to surgery for glioblastoma multiforme at high-volume commission on cancer-accredited hospitals in the United States. J Neurosurg 1(aop):1–10. https://doi.org/10.3171/2021.7.Jns211307
Lu VM, Shah AH, Eichberg DG, Quinones-Hinojosa A, Esquenazi Y, Komotar RJ, Ivan ME (2020) Geographic disparities in access to glioblastoma treatment based on hispanic ethnicity in the United States: insights from a national database. J Neurooncol 147(3):711–720. https://doi.org/10.1007/s11060-020-03480-1
Dressler EV, Liu M, Garcia CR, Dolecek TA, Pittman T, Huang B, Villano JL (2019) Patterns and disparities of care in glioblastoma. Neurooncol Pract 6(1):37–46. https://doi.org/10.1093/nop/npy014
Rechberger JS, Lu VM, Zhang L, Power EA, Daniels DJ (2020) Clinical trials for diffuse intrinsic pontine glioma: the current state of affairs. Childs Nerv Syst 36(1):39–46. https://doi.org/10.1007/s00381-019-04363-1
Bailey ZD, Krieger N, Agénor M, Graves J, Linos N, Bassett MT (2017) Structural racism and health inequities in the USA: evidence and interventions. Lancet 389(10077):1453–1463. https://doi.org/10.1016/s0140-6736(17)30569-x
Wafula EG, Snipes SA (2014) Barriers to health care access faced by black immigrants in the US: theoretical considerations and recommendations. J Immigr Minor Health 16(4):689–698. https://doi.org/10.1007/s10903-013-9898-1
Palmer NR, Weaver KE, Hauser SP, Lawrence JA, Talton J, Case LD, Geiger AM (2015) Disparities in barriers to follow-up care between African American and white breast cancer survivors. Support Care Cancer 23(11):3201–3209. https://doi.org/10.1007/s00520-015-2706-9
Catlett L, Campbell C (2021) Advance care planning and end of life care literacy initiatives in African American faith communities: a systematic integrative review. Am J Hosp Palliat Care 38(6):719–730. https://doi.org/10.1177/1049909120979164
Cheng BT, Wangmo T (2020) Palliative care utilization in hospitalized children with cancer. Pediatr Blood Cancer 67(1):e28013. https://doi.org/10.1002/pbc.28013
Paskett ED, Tatum CM, D’Agostino R Jr, Rushing J, Velez R, Michielutte R, Dignan M (1999) Community-based interventions to improve breast and cervical cancer screening: results of the Forsyth County Cancer Screening (FoCaS) project. Cancer Epidemiol Biomark Prev 8(5):453–459
Perkins SM, Rubin JB, Leonard JR, Smyth MD, El Naqa I, Michalski JM, Simpson JR, Limbrick DL, Park TS, Mansur DB (2011) Glioblastoma in children: a single-institution experience. Int J Radiat Oncol Biol Phys 80(4):1117–1121. https://doi.org/10.1016/j.ijrobp.2010.03.013
Lam S, Lin Y, Zinn P, Su J, Pan IW (2018) Patient and treatment factors associated with survival among pediatric glioblastoma patients: a surveillance, epidemiology, and end results study. J Clin Neurosci 47:285–293. https://doi.org/10.1016/j.jocn.2017.10.041
Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS (2011) An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 115(1):3–8. https://doi.org/10.3171/2011.2.jns10998
Wu M, Miska J, Xiao T, Zhang P, Kane JR, Balyasnikova IV, Chandler JP, Horbinski CM, Lesniak MS (2019) Race influences survival in glioblastoma patients with KPS ≥ 80 and associates with genetic markers of retinoic acid metabolism. J Neurooncol 142(2):375–384. https://doi.org/10.1007/s11060-019-03110-5
Funding
All authors report no funding sources or conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.
Author information
Authors and Affiliations
Contributions
VML: Methodology, Investigation, Data curation, Writing- Original draft preparation. All authors: Supervision, Writing- Reviewing and Editing.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lu, V.M., Niazi, T.N. Racial disparities in pediatric malignant glioma management: current state of affairs in the United States. J Neurooncol 160, 171–178 (2022). https://doi.org/10.1007/s11060-022-04130-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-022-04130-4